AAAAAA

   
Results: 1-16 |
Results: 16
COMPARISON OF 5-HT2A ANTAGONISTS M100907 AND RITANSERIN IN PRECLINICAL MODELS OF ANTIPSYCHOTIC ACTIVITY
Authors: SORENSEN SM MARTIN P HITCHCOCK JM
Citation: Sm. Sorensen et al., COMPARISON OF 5-HT2A ANTAGONISTS M100907 AND RITANSERIN IN PRECLINICAL MODELS OF ANTIPSYCHOTIC ACTIVITY, Schizophrenia research, 29(1-2), 1998, pp. 170-170
DEPOT DRUG FORMULATIONS IN PROCEDURES USED TO EVALUATE ANTIPSYCHOTIC ACTIVITY IN ANIMALS
Authors: WETTSTEIN JG SORENSEN SM HITCHCOCK JM LISTER S
Citation: Jg. Wettstein et al., DEPOT DRUG FORMULATIONS IN PROCEDURES USED TO EVALUATE ANTIPSYCHOTIC ACTIVITY IN ANIMALS, The FASEB journal, 12(4), 1998, pp. 790-790
NEONATAL HIPPOCAMPAL LESION MODEL OF SCHIZOPHRENIA IN RATS - SEX-DIFFERENCES AND PERSISTENCE OF EFFECTS INTO MATURITY
Authors: BLACK MD LISTER S HITCHCOCK JM VANGIERSBERGEN P SORENSEN SM
Citation: Md. Black et al., NEONATAL HIPPOCAMPAL LESION MODEL OF SCHIZOPHRENIA IN RATS - SEX-DIFFERENCES AND PERSISTENCE OF EFFECTS INTO MATURITY, Drug development research, 43(4), 1998, pp. 206-213
MIXED D-2 5-HT2A ANTAGONISM OF COCAINE-INDUCED FACILITATION OF BRAIN-STIMULATION REWARD/
Authors: TSIBULSKY VL GROCKI S DASHEVSKY BA KEHNE JH SCHMIDT CJ SORENSEN SM FRANK RA
Citation: Vl. Tsibulsky et al., MIXED D-2 5-HT2A ANTAGONISM OF COCAINE-INDUCED FACILITATION OF BRAIN-STIMULATION REWARD/, Pharmacology, biochemistry and behavior, 59(2), 1998, pp. 275-280
EFFECT OF (+ -)-7OH-DPAT ON THE ACTIVITY OF TYPE-I AND TYPE-II NEURONS IN THE SHELL OF THE NUCLEUS-ACCUMBENS/
Authors: HANAK SE SORENSEN SM WETTSTEIN JG BLACK MD
Citation: Se. Hanak et al., EFFECT OF (+ -)-7OH-DPAT ON THE ACTIVITY OF TYPE-I AND TYPE-II NEURONS IN THE SHELL OF THE NUCLEUS-ACCUMBENS/, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 3550-3550
GRANULOCYTE COLLECTION FROM GRANULOCYTE-COLONY-STIMULATING FACTOR PRIMED HLA IDENTICAL DONORS USING INTERMITTENT FLOW APHERESIS TECHNOLOGY
Authors: SORENSEN SM ATTAR T FANNING T AVALOS B
Citation: Sm. Sorensen et al., GRANULOCYTE COLLECTION FROM GRANULOCYTE-COLONY-STIMULATING FACTOR PRIMED HLA IDENTICAL DONORS USING INTERMITTENT FLOW APHERESIS TECHNOLOGY, Transfusion, 37(9), 1997, pp. 41-41
THE RECEPTOR-BINDING PROFILE OF MDL-100,907
Authors: VANGIERSBERGEN PLM BARON BM ELANDS J JOHNSON MP SORENSEN SM
Citation: Plm. Vangiersbergen et al., THE RECEPTOR-BINDING PROFILE OF MDL-100,907, Schizophrenia research, 18(2-3), 1996, pp. 4-4
RATIONALE FOR THE USE OF A SELECTIVE 5-HT2A RECEPTOR ANTAGONIST IN THE TREATMENT OF SCHIZOPHRENIA
Authors: SCHMIDT CJ FADAYEL GM SORENSEN SM KEHNE JH
Citation: Cj. Schmidt et al., RATIONALE FOR THE USE OF A SELECTIVE 5-HT2A RECEPTOR ANTAGONIST IN THE TREATMENT OF SCHIZOPHRENIA, Schizophrenia research, 18(2-3), 1996, pp. 11-11
PRECLINICAL PROFILE OF MDL-100907, A POTENT AND SELECTIVE 5-HT2A ANTAGONIST IN DEVELOPMENT FOR SCHIZOPHRENIA
Authors: SORENSEN SM CARR AA VANGIERSBERGEN PLM HITCHCOCK JM KEHNE JH SCHMIDT CJ
Citation: Sm. Sorensen et al., PRECLINICAL PROFILE OF MDL-100907, A POTENT AND SELECTIVE 5-HT2A ANTAGONIST IN DEVELOPMENT FOR SCHIZOPHRENIA, Schizophrenia research, 18(2-3), 1996, pp. 13-13
THE 5-HT2A ANTAGONIST MDL-100-907 BLOCKS DIZOCILPINE-INDUCED INCREASES IN THE FIRING RATE OF A10 DOPAMINE NEURONS
Authors: SORENSEN SM
Citation: Sm. Sorensen, THE 5-HT2A ANTAGONIST MDL-100-907 BLOCKS DIZOCILPINE-INDUCED INCREASES IN THE FIRING RATE OF A10 DOPAMINE NEURONS, Schizophrenia research, 15(1-2), 1995, pp. 21-21
MIXED D-2 5-HT2A ANTAGONISM OF AMPHETAMINE-INDUCED FACILITATION OF BRAIN-STIMULATION REWARD/
Authors: FRANK RA TSIBULSKY V GROCKI S DASHEVSKY B KEHNE JH SCHMIDT CJ SORENSEN SM
Citation: Ra. Frank et al., MIXED D-2 5-HT2A ANTAGONISM OF AMPHETAMINE-INDUCED FACILITATION OF BRAIN-STIMULATION REWARD/, Pharmacology, biochemistry and behavior, 52(4), 1995, pp. 799-804
THE ROLE OF 5-HT2A RECEPTORS IN ANTIPSYCHOTIC ACTIVITY
Authors: SCHMIDT CJ SORENSEN SM KEHNE JH CARR AA PALFREYMAN MG
Citation: Cj. Schmidt et al., THE ROLE OF 5-HT2A RECEPTORS IN ANTIPSYCHOTIC ACTIVITY, Life sciences, 56(25), 1995, pp. 2209-2222
PRECLINICAL ANTIPSYCHOTIC ACTIVITY OF A SELECTIVE 5HT(2) ANTAGONIST
Authors: SORENSEN SM SCHMIDT CJ HUMPHREYS TM PADICH RA KEHNE JH
Citation: Sm. Sorensen et al., PRECLINICAL ANTIPSYCHOTIC ACTIVITY OF A SELECTIVE 5HT(2) ANTAGONIST, Schizophrenia research, 11(2), 1994, pp. 115-115
ELECTROPHYSIOLOGICAL, BIOCHEMICAL AND BEHAVIORAL EVIDENCE FOR 5-HT(2)AND 5-HT(3) MEDIATED CONTROL OF DOPAMINERGIC FUNCTION
Authors: PALFREYMAN MG SCHMIDT CJ SORENSEN SM DUDLEY MW KEHNE JH MOSER P GITTOS MW CARR AA
Citation: Mg. Palfreyman et al., ELECTROPHYSIOLOGICAL, BIOCHEMICAL AND BEHAVIORAL EVIDENCE FOR 5-HT(2)AND 5-HT(3) MEDIATED CONTROL OF DOPAMINERGIC FUNCTION, Psychopharmacology, 112(1), 1993, pp. 190000060-190000067
CONTRIBUTION OF SEROTONIN NEUROTOXINS TO UNDERSTANDING PSYCHIATRIC-DISORDERS - THE ROLE OF 5-HT2 RECEPTORS IN SCHIZOPHRENIA AND ANTIPSYCHOTIC ACTIVITY
Authors: SCHMIDT CJ KEHNE JH CARR AA FADAYEL GM HUMPHREYS TM KETTLER HJ MCCLOSKEY TC PADICH RA TAYLOR VL SORENSEN SM
Citation: Cj. Schmidt et al., CONTRIBUTION OF SEROTONIN NEUROTOXINS TO UNDERSTANDING PSYCHIATRIC-DISORDERS - THE ROLE OF 5-HT2 RECEPTORS IN SCHIZOPHRENIA AND ANTIPSYCHOTIC ACTIVITY, International clinical psychopharmacology, 8, 1993, pp. 25-32
CHARACTERIZATION OF THE 5-HT(2) RECEPTOR ANTAGONIST MDL 100907 AS A PUTATIVE ATYPICAL ANTIPSYCHOTIC - BEHAVIORAL, ELECTROPHYSIOLOGICAL AND NEUROCHEMICAL STUDIES
Authors: SORENSEN SM KEHNE JH FADAYEL GM HUMPHREYS TM KETTELER HJ SULLIVAN CK TAYLOR VL SCHMIDT CJ
Citation: Sm. Sorensen et al., CHARACTERIZATION OF THE 5-HT(2) RECEPTOR ANTAGONIST MDL 100907 AS A PUTATIVE ATYPICAL ANTIPSYCHOTIC - BEHAVIORAL, ELECTROPHYSIOLOGICAL AND NEUROCHEMICAL STUDIES, The Journal of pharmacology and experimental therapeutics, 266(2), 1993, pp. 684-691
Risultati: 1-16 |